News
Zydus and MSN Launch First Generic Riociguat in US
Zydus and MSN are the first companies to launch a generic version of Adempas (riociguat) in the US market.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Zydus and MSN are the first companies to launch a generic version of Adempas (riociguat) in the US market.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
